tradingkey.logo

iSpecimen Inc

ISPC
0.330USD
-0.015-4.38%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
3.22MValor de mercado
PerdaP/L TTM

Mais detalhes de iSpecimen Inc Empresa

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

Informações de iSpecimen Inc

Código da empresaISPC
Nome da EmpresaiSpecimen Inc
Data de listagemJun 17, 2021
CEOField (Katharyn)
Número de funcionários24
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 17
Endereço8 Cabot Road
CidadeWOBURN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08101
Telefone17813016700
Sitehttps://www.ispecimen.com/
Código da empresaISPC
Data de listagemJun 17, 2021
CEOField (Katharyn)

Executivos da empresa iSpecimen Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Specimens – contracts with customers
95.82K
89.89%
Shipping and other
10.78K
10.11%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Specimens – contracts with customers
95.82K
89.89%
Shipping and other
10.78K
10.11%

Distribuição de ações

Atualizado em: seg, 17 de nov
Atualizado em: seg, 17 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
Outro
96.62%
Investidores
Investidores
Proporção
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
Outro
96.62%
Tipos de investidores
Investidores
Proporção
Hedge Fund
1.59%
Research Firm
0.86%
Investment Advisor
0.70%
Corporation
0.43%
Investment Advisor/Hedge Fund
0.43%
Individual Investor
0.26%
Outro
95.73%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
27
349.56K
3.58%
+223.90K
2025Q3
26
96.86K
1.75%
-11.14K
2025Q2
31
133.51K
3.29%
-45.19K
2025Q1
37
201.48K
8.20%
-43.25K
2024Q4
37
175.36K
18.22%
-42.87K
2024Q3
38
178.54K
25.34%
-4.65K
2024Q2
37
155.60K
21.84%
-23.10K
2024Q1
38
168.39K
35.92%
-17.71K
2023Q4
42
174.70K
38.71%
-30.54K
2023Q3
48
208.00K
46.18%
-25.86K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Renaissance Technologies LLC
153.46K
1.53%
+153.46K
--
Sep 30, 2025
Virtu Americas LLC
63.26K
0.63%
+63.26K
--
Sep 30, 2025
OBF Investments LLC
42.10K
0.42%
+1.00
+0.00%
Dec 31, 2024
Geode Capital Management, L.L.C.
41.69K
0.42%
+26.88K
+181.52%
Sep 30, 2025
Scientech Research LLC
29.49K
0.29%
+29.49K
--
Sep 30, 2025
The Vanguard Group, Inc.
29.41K
0.29%
+28.17K
+2277.28%
Sep 30, 2025
Wolf (James G)
25.25K
0.25%
-14.29K
-36.14%
Jun 03, 2024
Jane Street Capital, L.L.C.
20.26K
0.2%
+20.26K
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.83K
0.03%
--
--
Sep 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Data
Data ex-dividendo
Tipo
Proporção
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
KeyAI